Publications by authors named "Eva Papp"

Claim this Profile
T
The role of mannose binding lectin on fever episodes in pediatric oncology patients.
Ferenc Fekete, Balázs Fadgyas, Éva Papp, Ágnes Szilágyi, Zoltán Prohászka

Pathol Oncol Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead.
Michael Soth, Sarah Abbot, Allassan Abubakari, Nidhi Arora, Humberto Arzeno, Eva Papp

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors of p38α mitogen-activated protein kinase.
David M Goldstein, Michael Soth, Tobias Gabriel, Nolan Dewdney, Andreas Kuglstatter, Eva Papp

J Med Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase.
Joyce Kwan, Alden Ling, Eva Papp, David Shaw, J Michael Bradshaw

Anal Biochem· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes.
Armando G Villaseñor, Rama Kondru, Hoangdung Ho, Sandra Wang, Eva Papp

Chem Biol Drug Des· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Ronald J Hill, Karim Dabbagh, Deborah Phippard, Ching Li, Rebecca T Suttmann, Eva Papp

J Pharmacol Exp Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanism of the Syk activation switch.
Emily Tsang, Anthony M Giannetti, David Shaw, Marie Dinh, Joyce K Y Tse, Eva Papp

J Biol Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.
Eva Papp, Joyce K Y Tse, Hoangdung Ho, Sandra Wang, David Shaw

Biochemistry· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase.
David M Goldstein, Tom Alfredson, Jay Bertrand, Michelle F Browner, Ken Clifford, Eva Papp

J Med Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.
Alejandra Trejo, Humberto Arzeno, Michelle Browner, Sushmita Chanda, Soan Cheng, Eva Papp

J Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis